Holen Sie sich die Stockscreener-App
91.10
2.27%
-2.12
Vorhandelsmarkt:
91.67
0.57
+0.63%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$93.22
Offen:
$93.315
24-Stunden-Volumen:
6.47M
Relative Volume:
0.83
Marktkapitalisierung:
$116.77B
Einnahmen:
$33.54B
Nettoeinkommen (Verlust:
$4.69B
KGV:
25.17
EPS:
3.62
Netto-Cashflow:
$5.19B
1W Leistung:
-0.96%
1M Leistung:
+1.56%
6M Leistung:
+1.29%
1J Leistung:
+4.07%
1-Tages-Spanne:
$91.03
$93.79
1-Wochen-Bereich:
$87.50
$94.44
52-Wochen-Spanne:
$79.29
$96.25
Medtronic Plc Stock (MDT) Company Profile
Firmenname
Medtronic Plc
Sektor
Branche
Telefon
01135314381700
Adresse
BUILDING TWO PARKMORE BUSINESS PARK WEST, GALWAY
Vergleichen Sie MDT mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
MDT
Medtronic Plc
|
91.10 | 118.91B | 33.54B | 4.69B | 5.19B | 3.62 |
|
ABT
Abbott Laboratories
|
132.00 | 226.73B | 43.11B | 13.94B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
105.21 | 152.69B | 18.49B | 2.50B | 3.49B | 1.68 |
|
SYK
Stryker Corp
|
384.83 | 145.89B | 23.82B | 2.92B | 4.02B | 7.55 |
|
EW
Edwards Lifesciences Corp
|
81.16 | 45.97B | 5.69B | 1.41B | 577.90M | 6.95 |
Medtronic Plc Stock (MDT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-06-30 | Hochstufung | Wolfe Research | Underperform → Peer Perform |
| 2025-06-16 | Eingeleitet | Leerink Partners | Outperform |
| 2025-03-04 | Hochstufung | Citigroup | Neutral → Buy |
| 2024-10-10 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2024-08-21 | Bestätigt | Oppenheimer | Perform |
| 2024-08-15 | Hochstufung | UBS | Sell → Neutral |
| 2024-08-14 | Herabstufung | Stifel | Buy → Hold |
| 2024-05-30 | Eingeleitet | Goldman | Sell |
| 2023-07-19 | Eingeleitet | Robert W. Baird | Neutral |
| 2023-06-30 | Eingeleitet | CL King | Buy |
| 2023-05-30 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2023-04-24 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2023-03-29 | Herabstufung | UBS | Buy → Sell |
| 2023-01-09 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2022-11-23 | Herabstufung | Citigroup | Buy → Neutral |
| 2022-11-23 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2022-11-16 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2022-10-18 | Eingeleitet | Barclays | Equal Weight |
| 2022-10-13 | Eingeleitet | Mizuho | Buy |
| 2022-10-12 | Eingeleitet | Jefferies | Hold |
| 2022-08-24 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2022-07-06 | Eingeleitet | Wolfe Research | Underperform |
| 2022-06-01 | Herabstufung | Atlantic Equities | Overweight → Neutral |
| 2022-05-27 | Herabstufung | Needham | Buy → Hold |
| 2022-04-13 | Herabstufung | Truist | Buy → Hold |
| 2022-03-02 | Fortgesetzt | BofA Securities | Buy |
| 2022-01-10 | Herabstufung | BTIG Research | Buy → Neutral |
| 2022-01-07 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2022-01-04 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2021-12-17 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2021-12-16 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2021-12-10 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2021-06-10 | Fortgesetzt | Cowen | Outperform |
| 2021-05-25 | Eingeleitet | Barclays | Equal Weight |
| 2021-04-15 | Eingeleitet | Atlantic Equities | Overweight |
| 2020-12-15 | Hochstufung | Goldman | Sell → Neutral |
| 2020-12-15 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2020-10-08 | Hochstufung | Bernstein | Mkt Perform → Outperform |
| 2020-10-08 | Hochstufung | Stifel | Hold → Buy |
| 2020-09-11 | Eingeleitet | Wolfe Research | Peer Perform |
| 2020-05-14 | Herabstufung | DZ Bank | Buy → Hold |
| 2020-03-30 | Herabstufung | Needham | Strong Buy → Buy |
| 2020-03-25 | Hochstufung | DZ Bank | Hold → Buy |
| 2020-03-05 | Eingeleitet | Citigroup | Buy |
| 2020-02-13 | Eingeleitet | Goldman | Sell |
| 2020-01-08 | Eingeleitet | SunTrust | Buy |
| 2020-01-02 | Hochstufung | Guggenheim | Neutral → Buy |
| 2019-06-05 | Hochstufung | Wells Fargo | Market Perform → Outperform |
| 2019-02-04 | Bestätigt | Needham | Strong Buy |
| 2019-01-03 | Eingeleitet | Deutsche Bank | Buy |
| 2019-01-02 | Herabstufung | Citigroup | Buy → Neutral |
| 2018-12-19 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2018-11-28 | Eingeleitet | UBS | Buy |
| 2018-10-16 | Eingeleitet | Barclays | Overweight |
| 2018-08-27 | Bestätigt | Argus | Buy |
Alle ansehen
Medtronic Plc Aktie (MDT) Neueste Nachrichten
Why Medtronic Stock Raced Higher Today - AOL.com
Why Medtronic Stock Raced Higher Today - The Motley Fool
Wells Fargo Raises Medtronic (MDT) Price Target Amid Positive Outlook | MDT Stock News - GuruFocus
Medtronic (MDT) Sees Price Target Raised by UBS Analyst Today | MDT Stock News - GuruFocus
Medtronic Has Potential To Pursue Further Divestitures: Analyst - Benzinga
These Analysts Boost Their Forecasts On Medtronic After Upbeat Q1 Earnings - Benzinga
Truist Securities Adjusts Price Target on Medtronic to $96 From $92, Maintains Hold Rating - MarketScreener
Medtronic’s Unexpected Surge: Analyzing the Performance - StocksToTrade
Why Medtronic (MDT) is a Top Value Stock for the Long-Term - Yahoo Finance
UBS Adjusts Price Target on Medtronic to $95 From $94, Maintains Neutral Rating - MarketScreener
Medtronic plc (NYSE:MDT) Q1 2026 Earnings Call Transcript - MSN
How Medtronic Plc. (MDT) Affects Rotational Strategy Timing - news.stocktradersdaily.com
Goldman Sachs Adjusts Medtronic Price Target to $82 From $78 - MarketScreener
RBC Capital Adjusts Price Target on Medtronic to $103 From $101 - MarketScreener
Leerink Partners Adjusts Price Target on Medtronic to $111 From $110, Maintains Outperform Rating - MarketScreener
JPMorgan Adjusts Price Target on Medtronic to $90 From $87, Maintains Neutral Rating - MarketScreener
Evercore ISI Adjusts Price Target on Medtronic to $107 From $106, Maintains Outperform Rating - MarketScreener
Wells Fargo Adjusts Price Target on Medtronic to $100 From $98, Maintains Overweight Rating - MarketScreener
Bernstein Adjusts Price Target on Medtronic to $98 From $97, Maintains Outperform Rating - MarketScreener
Medtronic heads into Q1 with softer profit sentiment - MSN
Medtronic: Fiscal Q1 Earnings Snapshot - Greenwich Time
Medtronic PLC (MDT) Q1 2026 Earnings Call Highlights: Strong Revenue Growth and Raised EPS Guidance - Yahoo Finance
Medtronic Reports Strong Q1, Driven By Cardiac Technology And Product Innovation - Patch
Medtronic Adds Directors, Forms Strategic Committees After Elliott Stake - Patch
Medtronic Reports Strong Q1 FY26 Results - TipRanks
Medtronic Posts 7 Percent Growth in Q1 - sharewise.com
Activist Investor Group Indicates a Shift for Medtronic - Medical Device and Diagnostic industry
Medtronic sees 72% uptick in PFA in US - BioWorld MedTech
Medtronic plc. (MDT) Stock Forecasts - Yahoo Finance
Medtronic Sees Tariffs Adding $185M To Costs This Year - Law360
Medtronic Expands Board to Explore M&A After Engagement with Elliott Investment Management - MarketScreener
Why Medtronic Stock Dropped Today - AOL.com
Cardiac Assist Devices Market to Grow at 13.7% CAGR with FDA Breakthroughs and Pipeline Momentum from Abbott, Medtronic, and Abiomed | DelveInsight - Barchart.com
Medtronic to change board as Elliott becomes major investor - MSN
Medtronic plc Reaches Critical Trendline Support2025 Institutional Moves & AI Driven Price Predictions - thegnnews.com
Medtronic: The Opportunity Gets Healthier for Income Investors - MSN
Medtronic Earnings: Solid Results Keep Firm on Track for Fiscal 2026 - Morningstar
Stifel Lifts Price Target on Medtronic to $90 From $87 - MarketScreener
Medtronic Lifts Outlook After Strong Results And Guidance Update - Finimize
Medtronic (MDT) Reports US$8,578 Million Q1 Sales and Appoints New Directors - Yahoo Finance
Nasdaq Down Over 300 Points; Medtronic Posts Upbeat Earnings - Benzinga
Medtronic adds 2 board seats, forms special committees - medtechdive.com
Medtronic plans to add two independent directors after Elliott takes large stake - MSN
Medtronic to add two new directors after Elliott takes large stake - Reuters
Medtronic lifts FY26 outlook amid 50% growth in cardiac ablation - Medical Device Network
Medtronic (MDT) Raises Full-Year EPS Guidance on Strong Q1 Performance - GuruFocus
Medtronic recall of heart vent catheters tied to 3 serious injuries - medtechdive.com
Medtronic plc Reports Earnings Results for the First Quarter Ended July 25, 2025 - MarketScreener
Medtronic Boosts Earnings Outlook on Lower Projected Tariff Hit - Bloomberg.com
Medtronic Lifts Annual Outlook, Appoints New Directors In Post-Elliott Strategic Shift - AOL.com
Medtronic Raises Full-Year Earnings Outlook; Appoints Two New Board Members After Elliott Investment Talks - MarketScreener
Finanzdaten der Medtronic Plc-Aktie (MDT)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.80%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):